Vitamin B12 and folate: deficiency, anaemia, and the nervous system

Vitamin B12 and folate are essential for two critical processes: red blood cell maturation and normal nervous system function. Deficiency of either can cause anaemia — and B12 deficiency can also cause neurological damage that gives no warning signs in its early stages. That is the central danger: symptoms appear late, when the process is already well underway.

The most important thing to know about B12 deficiency: neurological complications can be irreversible if treatment is started too late. Deficiency caught early is a condition that responds well to correction. Left untreated, it can cause lasting damage even after blood B12 levels have been restored.

This article explains what B12 and folate tests measure, how to read results, which values are cause for concern, and who should be tested first.

This is not a substitute for a medical consultation, but it will help you make sense of your report and ask the right questions at your appointment.

The role of B12 and folate

Both vitamins are involved in DNA synthesis and cell division. The tissues most sensitive to their deficiency are those with rapid cell turnover: bone marrow and mucosal linings. When B12 or folate is insufficient, red blood cells fail to mature normally — instead of regular normocytes, the blood contains large, immature forms called macrocytes. This is how megaloblastic anaemia develops.

B12 also participates in myelin synthesis — the protective sheath around nerve fibres. This is why B12 deficiency, unlike folate deficiency, produces neurological symptoms. Folate cannot substitute for B12 in this function.

Both vitamins share another metabolic pathway: the conversion of homocysteine. When either vitamin is deficient, homocysteine accumulates in the blood. Elevated homocysteine is associated with cardiovascular risk, though the causal relationship remains an area of ongoing research.

A practical distinction: if megaloblastic anaemia is found, it is important to determine which vitamin is actually deficient. Treatment is not interchangeable — correcting a B12 deficiency with folate alone may temporarily improve blood counts but will not halt neurological damage and can mask its progression.

B12 reference range and “gray zone”

Serum B12 is the most common initial screening method. It is accessible, relatively inexpensive, and included in many standard panels. One important limitation: serum B12 reflects the total amount of the vitamin in the blood, not necessarily its functional availability to cells.

Serum B12	Interpretation
< 148 pmol/L (~200 pg/mL)	Deficiency
148–221 pmol/L (~200–300 pg/mL)	Gray zone (borderline)
> 221 pmol/L (~300 pg/mL)	Normal

Units vary by laboratory — pmol/L or pg/mL. The specific reference limits depend on the assay method, so always check the reference range printed on your own report.

The gray zone is not “all clear.” Per BSH guidelines (2014), when B12 falls within 148–221 pmol/L and clinical suspicion of deficiency exists, it is appropriate to test functional markers: methylmalonic acid or homocysteine. The clinical decision rests with your doctor.

Methylmalonic acid and homocysteine

When B12 is in the gray zone, or the clinical picture is inconsistent with the result, two supplementary markers are used.

Methylmalonic acid (MMA) is a specific marker of functional B12 deficiency. B12 is required to convert MMA to succinyl-CoA; when it is lacking, MMA accumulates. Elevated MMA with a normal or borderline serum B12 indicates that cells are already experiencing B12 insufficiency, even when the serum level appears adequate.

Homocysteine rises with deficiency of either B12 or folate, as well as with impaired kidney function and certain genetic conditions. It is less specific but useful in an overall assessment. Elevated homocysteine with a normal B12 may point to folate deficiency.

In practice, these markers are not ordered routinely — they are used in specific clinical situations: symptoms present but B12 in the gray zone, or a B12 result that is difficult to interpret. They are not part of standard screening, but are a valuable tool for your doctor when clarifying a diagnosis.

For reference: MMA can be measured in urine or serum; the urinary method is simpler and sufficient for most clinical situations. A result exceeding the laboratory’s upper reference limit is considered significantly elevated.

Folate reference range

Serum folate is normally above 7 nmol/L (3 ng/mL), though reference limits vary between laboratories. An important limitation of serum folate is that it reflects recent intake rather than long-term status. A few days of adequate eating can normalise serum folate even in the setting of chronic deficiency.

Red blood cell (RBC) folate is more accurate for assessing long-term status: red cells “record” the conditions of their maturation over the preceding two to three months. This test is ordered less frequently, usually at the doctor’s discretion.

Important: folate is especially critical in early pregnancy — the first four weeks after conception — for correct neural tube formation. Women planning a pregnancy are advised to start folate supplementation before conception and continue through the first trimester. This falls outside laboratory interpretation and should be discussed with your doctor.

Megaloblastic anaemia

Deficiency of B12 or folate leads to megaloblastic anaemia — a form of macrocytic anaemia in which MCV exceeds 100 fL. A characteristic finding on a blood film is hypersegmented neutrophils (five or more nuclear segments).

Importantly, macrocytosis and neutrophil changes can appear before anaemia itself develops — meaning haemoglobin may still be normal while the bone marrow is already working under deficiency conditions. This is why doctors often check B12 and folate when an elevated MCV is found on a complete blood count, even without a haemoglobin drop.

Keep in mind that macrocytosis has other causes beyond B12 or folate deficiency. Excess alcohol, thyroid disease, and certain medications (methotrexate, hydroxyurea) also raise MCV. Differential diagnosis is the doctor’s responsibility — an isolated MCV result should not be interpreted independently.

Neurological symptoms of B12 deficiency

This is the most critical aspect of B12 deficiency. Neurological symptoms develop through demyelination — damage to the myelin sheath of nerve fibres:

Paraesthesias — tingling, numbness, “pins and needles,” typically symmetrical in the feet and hands
Coordination and gait disturbance — unsteadiness, especially in low light (impaired proprioception)
Cognitive changes — memory and concentration difficulties; in severe or neglected cases, dementia
Mood symptoms — irritability, low mood

A critically important detail: neurological symptoms can precede anaemia. B12 in the blood is already low and myelin is already being damaged — but haemoglobin is still normal and there is no formal “anaemia.” Relying on haemoglobin alone makes it easy to miss B12 deficiency entirely.

Delayed treatment carries a real risk of irreversibility: some neurological changes do not recover even after B12 levels have been normalised. This is why, in the presence of characteristic symptoms — symmetrical limb paraesthesias, gait disturbance, cognitive complaints — it is not appropriate to wait for haemoglobin to fall.

A specific clinical scenario is subacute combined degeneration of the spinal cord: damage to the posterior and lateral columns that develops with prolonged B12 deficiency. It begins with paraesthesias and impaired vibration sense and can progress to ataxia. Early diagnosis fundamentally changes the prognosis.

Risk groups for B12 deficiency

Testing for B12 is worth considering in the presence of any of the following factors. Folate deficiency is more often linked to diet, malabsorption, and alcohol — but clinical assessment is always individualised.

Vegans and strict vegetarians — B12 is found almost exclusively in animal-source foods; without supplements or fortified products, deficiency is inevitable
Long-term metformin use (particularly beyond four years) — the drug reduces B12 absorption in the small intestine; the ADA and NICE recommend periodic monitoring
Long-term proton pump inhibitor use (omeprazole and others) beyond two years — reduced gastric acid impairs the release of B12 from food
Atrophic gastritis — reduced production of intrinsic factor, which is required for B12 absorption
Post-gastrectomy or bariatric surgery — partial or complete loss of the cells that produce intrinsic factor
Small bowel disease — coeliac disease, Crohn’s disease, malabsorption syndromes
Age over 60 — gradual decline in intrinsic factor production and gastric acid secretion

It is worth noting that risk factors often overlap in practice. For example, a woman who has had bariatric surgery, follows a vegetarian diet, and takes a PPI carries several risk factors simultaneously. In such situations, systematic B12 monitoring is especially important.

Iron deficiency, which also frequently presents with anaemia, is a separate reason to investigate — for more on ferritin and iron stores, see the article on ferritin.

How HealthLab helps track trends

For people in risk groups, B12 and folate are most informative as a trend: a single result gives only a snapshot, whereas a series of data points shows whether correction is responding to supplementation or whether deficiency returns after treatment stops.

This is particularly true for people taking metformin or following a plant-based diet — regular B12 monitoring here is not overcaution, but a justified approach to preventing irreversible outcomes.

HealthLab automatically recognises B12, folate, MCV, and other biomarkers from PDF lab reports issued by any laboratory and builds a trend chart over time. You see the pattern without manual data entry. All results are stored in one place — easy to show your doctor or to track your response to dietary or supplementation changes.

Download HealthLab on the App Store

Frequently asked questions

My B12 is in the gray zone (200–300 pg/mL) — is that deficiency or not?

It might be. Serum B12 in the range of 200–300 pg/mL (~148–221 pmol/L) does not give a clear-cut answer: some people with this result have functional deficiency at the cellular level. Per BSH guidelines (2014), when clinical suspicion is present, testing methylmalonic acid (MMA) or homocysteine is useful — they will show whether cells are actually short of the vitamin. The decision on next steps is made with your doctor.

Should I test for folate separately or together with B12?

Usually together. Megaloblastic anaemia can develop with deficiency of either vitamin, and the two look identical on blood tests — you cannot tell them apart without further investigation. At the same time, their functional markers differ: MMA is specific to B12, while an isolated homocysteine elevation with normal B12 and MMA can point to folate deficiency. Ordering both tests at once therefore gives a more complete picture. The specific panel is determined by your doctor based on the clinical situation.

I take metformin — how often should I check B12?

There is no single universal protocol, but both NICE and the ADA recommend attention to B12 status with long-term metformin use — particularly if the course exceeds four years or symptoms that might indicate deficiency are present (paraesthesias, fatigue, cognitive changes). Some clinical guidelines suggest checking B12 annually during long-term treatment. Agree on a specific schedule with the doctor managing your therapy.

I am vegetarian — is it safe to skip testing?

It depends on the type of diet. Lacto-ovo vegetarians (dairy and eggs included) obtain some B12 and have a lower risk than strict vegans. However, even with regular dairy consumption, B12 levels can fall below optimal. Vegans without supplementation will almost always develop deficiency — the only question is when. A baseline B12 check every one to two years is a sensible approach for any vegetarian diet; for vegans it is essential.